Mangoceuticals reported revenue of $0.07M and net income of -$1.31M for the quarter ended Jun 2026, down 59.1% year over year. This income statement covers 15 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||
| Revenue | 0.10M | 0.14M | 0.25M | 0.24M | 0.21M | 0.16M | 0.13M | 0.11M | 0.11M | 0.17M | 0.08M | 0.09M | 0.07M | 0.07M | |
| Cost of RevenueCost of Rev | 0.02M | 0.03M | 0.05M | 0.05M | 0.02M | 0.03M | 0.02M | 0.02M | 0.02M | 0.02M | 0.00M | 0.01M | 0.01M | 0.01M | |
| Gross Profit | 0.06M | 0.09M | 0.14M | 0.14M | 0.15M | 0.07M | 0.08M | 0.08M | 0.06M | 0.09M | 0.05M | 0.05M | 0.03M | 0.04M | |
| Operating items | |||||||||||||||
| Amortization - Intangibles | 0.28M | 0.28M | |||||||||||||
| Selling, General & AdministrativeSG&A | 0.13M | 0.57M | 0.54M | 0.82M | 0.77M | 0.85M | 0.52M | 0.85M | 1.54M | 1.25M | 0.31M | 0.66M | 1.05M | 0.26M | |
| Other Operating ExpensesOther Opex | 2.49M | 1.81M | 1.40M | 1.89M | 1.74M | 1.39M | 1.32M | 0.90M | 3.10M | 4.11M | 7.28M | -0.24M | 2.10M | 0.82M | |
| Operating ExpensesOpex | 2.62M | 2.38M | 1.94M | 2.71M | 2.52M | 2.24M | 1.84M | 1.76M | 4.64M | 5.36M | 7.59M | 0.42M | 3.16M | 1.08M | |
| Operating IncomeOp. Inc | -2.56M | -2.29M | -1.80M | -2.57M | -2.37M | -2.17M | -1.76M | -1.68M | -4.58M | -5.27M | -7.54M | -0.37M | -3.13M | -1.03M | |
| EBIT | -2.56M | -2.29M | -1.80M | -2.57M | -2.37M | -2.17M | -1.76M | -1.68M | -4.58M | -5.27M | -7.54M | -0.37M | -3.13M | -1.03M | |
| Non-operating items | |||||||||||||||
| Non Operating Interest Expenses | -0.01M | 0.02M | 0.08M | 0.02M | |||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.13M | 0.11M | |||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.00M | 0.01M | -0.22M | -0.24M | -0.27M | -0.26M | -0.15M | -0.08M | -2.40M | -0.28M | -0.28M | ||||
| Net income details | |||||||||||||||
| EBT | -2.56M | -2.28M | -1.80M | -2.57M | -2.37M | -2.39M | -2.00M | -1.95M | -4.84M | -5.42M | -7.62M | -2.77M | -3.40M | -1.31M | |
| Profit After TaxPAT | -2.56M | -2.28M | -1.80M | -2.57M | -2.37M | -2.39M | -2.00M | -1.95M | -4.84M | -5.42M | -7.62M | -2.77M | -3.40M | -1.31M | |
| Income from Non-Controlling InterestsInc. Minority | -1.80M | -36.00 | -340.00 | -461.00 | -244.00 | -98.00 | -2.00 | -558.00 | 197.00 | -0.00M | -278.00 | ||||
| Income from Continuing OperationsIncome (Continuing) | -2.56M | -2.28M | -1.80M | -2.57M | -2.37M | -2.39M | -2.00M | -1.95M | -4.84M | -5.42M | -7.62M | -2.77M | -3.40M | -1.31M | |
| Consolidated Net IncomeConsol Net Inc. | -2.56M | -2.28M | -1.80M | -2.57M | -2.37M | -2.39M | -2.00M | -1.95M | -4.84M | -5.42M | -7.62M | -2.77M | -3.40M | -1.31M | |
| Income towards Parent CompanyParent Net Inc | -2.56M | -2.28M | -1.80M | -2.57M | -2.37M | -2.39M | -2.00M | -1.95M | -4.84M | -5.42M | -7.62M | -2.77M | -3.40M | -1.31M | |
| Preferred Dividend PaymentsPref Dividends | 0.29M | 0.29M | 0.29M | 0.29M | 0.29M | 0.29M | 0.29M | ||||||||
| Net Income towards Common StockholdersNet Income | -2.56M | -2.28M | -1.80M | -2.57M | -2.37M | -2.39M | -2.29M | -1.95M | -5.13M | -5.71M | -7.91M | -3.06M | -3.70M | -1.61M | |
| Additional items | |||||||||||||||
| EPS (Basic) | -3.41 | -2.17 | -1.70 | -2.39 | -1.56 | -1.37 | -1.14 | -0.98 | -1.12 | -0.57 | -0.69 | -0.30 | -0.22 | -0.09 | |
| EPS (Diluted) | -3.41 | -2.17 | -1.70 | -2.39 | -1.56 | -1.37 | -1.14 | -0.98 | -1.12 | -0.57 | -0.69 | -0.30 | -0.22 | -0.09 | |
| Shares Outstanding | 0.72M | 0.75M | 1.05M | 1.06M | 1.07M | 1.52M | 1.74M | 2.01M | 1.98M | 4.59M | 9.98M | 11.52M | 10.07M | 16.48M | 17.12M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.72M | 0.75M | 1.05M | 1.06M | 1.07M | 1.52M | 1.74M | 2.01M | 1.98M | 4.59M | 9.98M | 11.52M | 10.07M | 16.48M | 17.12M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.72M | 0.75M | 1.11M | 1.12M | 1.07M | 1.57M | 1.94M | 2.13M | 1.98M | 4.59M | 10.64M | 11.52M | 10.07M | 16.97M | 18.02M |
| EBITDA | -2.56M | -2.29M | -1.80M | -2.57M | -2.37M | -2.17M | -1.76M | -1.68M | -4.58M | -5.27M | -7.54M | -0.37M | -3.13M | -1.03M | |
| Interest ExpensesInt Expense | -0.01M | 0.02M | 0.08M | 0.02M |